期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 93, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2023.129411
关键词
Carbonic anhydrase; Drug design; Inhibitor; Activator; Inhibition/activation mechanisms; Anticancer agent; Antiobesity drug; Antiinfectives; Cognitive disorders; Sulfonamide; Coumarin; SLC-0111
This article presents advances in carbonic anhydrase (CA, EC 4.2.1.1) research over the past three decades, focusing on the understanding of the activation mechanism, the development of isoform-selective inhibitors/activators using the tail approach, and their applications in obesity management, hypoxic tumors, neurological conditions, and as anti-infectives.
Advances in the carbonic anhydrase (CA, EC 4.2.1.1) research over the last three decades are presented, with an emphasis on the deciphering of the activation mechanism, the development of isoform-selective inhibitors/ activators by the tail approach and their applications in the management of obesity, hypoxic tumors, neurological conditions, and as antiinfectives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据